AFC-HD AMS Life Science Co.,Ltd. Logo

AFC-HD AMS Life Science Co.,Ltd.

An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.

2927 | T

Overview

Corporate Details

ISIN(s):
JP3124700000
LEI:
Country:
Japan
Address:
静岡市駿河区豊田3丁目6番36号

Description

AFC-HD AMS Life Science Co., Ltd. is a comprehensive Original Equipment Manufacturer (OEM) specializing in the development, manufacturing, and sale of health foods, dietary supplements, and cosmetics. The company operates across both the healthcare and pharmaceutical business segments. Through its group subsidiaries, it manages a vertically integrated model encompassing research and development, GMP-certified production, and distribution channels such as mail-order sales and wholesale. Key activities include the R&D of innovative supplements through its preventive medical laboratory and the creation of health-related media content. The company delivers a wide spectrum of quality products to meet diverse customer needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-01-15 05:58
確認書
Japanese ZIP 8.9 KB
2024-01-15 05:57
四半期報告書-第44期第1四半期(2023/09/01-2023/11/30)
Japanese ZIP 214.8 KB
2023-11-29 05:28
臨時報告書
Japanese ZIP 27.0 KB
2023-11-28 06:24
確認書
Japanese ZIP 8.9 KB
2023-11-28 06:23
有価証券報告書-第43期(2022/09/01-2023/08/31)
Japanese ZIP 1.2 MB
2023-11-28 06:23
内部統制報告書-第43期(2022/09/01-2023/08/31)
Japanese ZIP 23.6 KB
2023-07-14 08:02
確認書
Japanese ZIP 8.9 KB
2023-07-14 08:02
四半期報告書-第43期第3四半期(2023/03/01-2023/05/31)
Japanese ZIP 201.5 KB
2023-04-14 08:05
確認書
Japanese ZIP 8.9 KB
2023-04-14 08:04
四半期報告書-第43期第2四半期(2022/12/01-2023/02/28)
Japanese ZIP 246.3 KB
2023-01-13 07:09
確認書
Japanese ZIP 8.9 KB
2023-01-13 07:08
四半期報告書-第43期第1四半期(2022/09/01-2022/11/30)
Japanese ZIP 197.6 KB
2022-11-30 07:04
内部統制報告書-第42期(令和3年9月1日-令和4年8月31日)
Japanese ZIP 23.7 KB
2022-11-30 07:03
有価証券報告書-第42期(令和3年9月1日-令和4年8月31日)
Japanese ZIP 1.1 MB
2022-11-30 07:03
確認書
Japanese ZIP 9.0 KB

Automate Your Workflow. Get a real-time feed of all AFC-HD AMS Life Science Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AFC-HD AMS Life Science Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AFC-HD AMS Life Science Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.